Leveraging mHealth Data For Product Development: FDA-Supported Action Plan Released

Mobile health devices including wearable consumer products have the potential to collect a lot of medical information that can be useful for product development and tracking. A new action plan from US FDA, industry and other key players outlines ways to harness and use that data to bring better products to market more quickly.

A working group of US FDA and industry stakeholders say mobile health technology holds huge potential for advancing medical research, particularly as tools to collect and share data. A new action plan published by the group proposes several steps to help reap that potential.

The Duke-Margolis Center for Health Policy unveiled the report Sept. 15, which lays out recommendations falling under five...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

Relief Cardiovascular Brings Relief To Heart Failure Patients With Smart Transcatheter Implant

 

Successful implantations of a novel transcatheter mark a major step forward in treating congestion in heart failure, according to the California -based company that developed it. The procedure was part of a feasibility study evaluating the device’s safety.

AdvaMed Warns Of Challenges With Remote Devices While Noting Their Potential

 

Though the advance of remote medical device technology allows for better at-home care, it comes with challenges and risks, says AdvaMed, which has published a safety bulletin guiding stakeholders on the operation of remote devices.

Confido CEO Predicts AI For Repetitive Tasks Will Become As Essential To Clinics As Basic Hygiene

 
• By 

Confido Health has raised $10m in Series A funding to expand its AI voice agent from patient scheduling into referrals, prescriptions and billing, bringing the total collected to $13m. CEO Chetan Reddy predicts in the next decade, AI use for admin tasks in healthcare will become mainstream.

FDA Wants Help In Figuring Out How AI-Enabled Devices Work In ‘The Real World’

 

The US FDA is seeking public input on practical approaches to evaluating the performance of AI-enabled medical devices. The agency says it wants to build off insights gained from a public advisory committee last year that discussed how best to evaluate these devices once they are in use.

More from Medtech Insight

Real-World Evidence Can Help Overcome Regulatory and Market Barriers for Pediatric Medical Devices

 
• By 

At AdvaMed’s MedTech Conference in San Diego, speakers brainstorm ways to bring devices to treat children to market more quickly through creative collaboration, better use of real-world data, and taking advantage of ‘low-hanging fruit’ like expanded size ranges.

AdvaMed Warns Of Challenges With Remote Devices While Noting Their Potential

 

Though the advance of remote medical device technology allows for better at-home care, it comes with challenges and risks, says AdvaMed, which has published a safety bulletin guiding stakeholders on the operation of remote devices.

Case Study: Pushing The EU’s IVD Regulation To Its Limits With Next Generation Sequencing

 

Partnership, positive communication and passion were all key in establishing a regulatory route for groundbreaking genetic testing technology for hereditary diseases. So said Fulgent Genetics’ executives interviewed by MTI about their technology’s development pathway.